Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anemia × Goserelin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Classical hematology 1

Conditions

Prostatic Neoplasms 121 Breast Neoplasms 84 Neoplasms 6 Breast Neoplasms, Male 6 Neoplasm Metastasis 5 Salivary Gland Neoplasms 3 Prostate Adenocarcinoma 3 Advanced Breast Cancer 3 Recurrence 2 Osteoporosis 2 Leiomyoma 2 Infertility 2 Advanced Prostate Cancer 2 Triple Negative Breast Neoplasms 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Sexual Dysfunction, Physiological 1 Radiation Injuries 1 Primary Ovarian Insufficiency 1 Primary Dysautonomias 1 Patient Compliance 1 PSA Level Greater Than Two 1 Ovarian Neoplasms 1 Osteitis Deformans 1 Myofibroma 1 Lymphatic Metastasis 1 Kidney Diseases 1 Inflammatory Breast Neoplasms 1 Hypertension 1 Hyperlipidemias 1 Hot Flashes 1

Interventions

Epoetin Alfa 51 Darbepoetin alfa 35 epoetin beta 14 ferric carboxymaltose 11 Cyclophosphamide 5 luspatercept 4 fludarabine phosphate 4 fludarabine 4 Erythropoietin 4 Cyclosporine 4 Cisplatin 4 Busulfan 4 Blood Transfusion 4 ACE-011 4 peginesatide 3 hematide 3 ferrous sulfate 3 ferric gluconate 3 Radiotherapy 3 Lenalidomide 3 Iron-Dextran Complex 3 Filgrastim 3 Erythrocyte Transfusion 3 Biopsy 3 Antilymphocyte Serum 3 thymoglobulin 2 ruxolitinib 2 iron isomaltoside 1000 2 ferrous fumarate 2 continuous erythropoietin receptor activator 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00303784 2020-11-27

PATCH

University College, London

Phase 3 Unknown

Classical hematologyGenitourinary

Anemia, Osteoporosis, Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡